HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

trifluoroacetyl- leucyl- alanyl- 4- trifluoromethylanilide

structure given in first source

Also Known As:

CF3-Leu-Ala-NH-C6H4-CF3; TFLA

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - trifluoroacetyl-leucyl-alanyl-4-trifluoromethylanilide: 3

Experts

1.	Lee, Kyoung Kyu: 1 article (04/2019)
2.	Lee, Sang Ho: 1 article (04/2019)
3.	Park, Chan Hong: 1 article (04/2019)
4.	Almeida, António J: 1 article (01/2016)
5.	Carvalheiro, Manuela: 1 article (01/2016)
6.	Cruz, M Eugénia M: 1 article (01/2016)
7.	Eleutério, Carla V: 1 article (01/2016)
8.	Esteves, M Alexandra: 1 article (01/2016)
9.	Gaspar, M Manuela: 1 article (01/2016)
10.	Gonçalves, Lídia: 1 article (01/2016)

Related Diseases

1.	Infections 01/01/2012 - "The transgenic potato expressing tflA also showed resistance to Burkholderia glumea infection." 01/01/2016 - "To improve the potential of trifluralin (TFL) in the management of Leishmania infantum infections through the synthesis of analogs (TFLA) and incorporation in nanoparticulate drug delivery systems (NanoDDS), liposomes and solid lipid nanoparticles, for selective targeting to leishmania infection sites. "
2.	Low Back Pain (Lumbago) 04/01/2019 - "Our results indicate that annuloplasty is a reasonable treatment option for carefully selected patients with lower back and radicular pain of discogenic origin, and TFLA might be superior to IDRA in patients with discogenic low back pain."
3.	Pain (Aches) 04/01/2019 - "Among patients undergoing TFLA, 70.3% (n = 26) reported pain relief (NRS scores < 50% of baseline) at post-treatment 6 months, vs. 58.1% (n = 25) of those undergoing IDRA. " 04/01/2019 - "Our results indicate that annuloplasty is a reasonable treatment option for carefully selected patients with lower back and radicular pain of discogenic origin, and TFLA might be superior to IDRA in patients with discogenic low back pain."
4.	Leishmaniasis 01/01/2016 - "To improve the potential of trifluralin (TFL) in the management of Leishmania infantum infections through the synthesis of analogs (TFLA) and incorporation in nanoparticulate drug delivery systems (NanoDDS), liposomes and solid lipid nanoparticles, for selective targeting to leishmania infection sites. "

Related Drugs and Biologics

1.	Trifluralin
2.	Liposomes (Liposome)
3.	Lipid Nanoparticles